Wu says FTC has law on its side

Timothy Wu, who was the intellectual architect of much of the Biden administration’s competition policy, says the US has moved to an antitrust era that connects to democratic roots. Congressional intent assures its longevity, he told FTCWatch in a...

Neill Averitt

Amgen-Horizon case raises possibility of personalized merger law

At first glance, the Federal Trade Commission’s complaint targeting the Amgen-Horizon deal seems ill-conceived and overbroad, but on second look there may be a hidden logic behind it. The history of the two companies could also become a factor in the analysis.

Current Issue: 785

ACOs and antitrust guidance: burdensome, unclear, and expensive?

The government’s proposed guidance on antitrust scrutiny for Accountable Care Organizations may have generated more questions than answers.

Senate dials up scrutiny: Cell phone merger questioned

Cell phone executives appeared before the Senate Subcommittee on Antitrust, Competition Policy and Consumer Rights to answer questions related to AT&T’s plan to acquire T-Mobile, a deal rumored to...

Privacy on the go: Mobile technology hearing

The Senate Subcommittee on Privacy, Technology and the Law met for the first time on May 10, hearing testimony from the FTC, Justice Department, Apple, Google, and privacy experts related to...

Commissioner Brill to industry: Be like a superhero

At a recent conference, FTC Commissioner Julie Brill challenged attendees to “be a little like Spider Man.”

Changing the supermarket landscape?

Four government agencies seek public comments on proposed nutrition guidelines that aim to change the foods companies market to American children, a proposal that the government hopes will...

Global drug deal announced

Two global drug companies have plans to “become a leader in specialty pharma” through a transaction valued at $6.8 billion.




Access all archived issues back to 1994